Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Return on Sales (2020 - 2026)

Longeveron (LGVN) posted quarterly Return on Sales of 0.14% for Q1 2026, up 3.0% year-over-year from 0.14% in Q1 2025, and up 18.66% quarter-over-quarter from 0.17% in Q4 2025.

Longeveron (LGVN) Return on Sales (2020 - 2026) Analysis & Trends

Longeveron's Return on Sales history runs 7 years deep, the most recent figure standing at 0.14% for Q1 2026.

  • In Q1 2026, Return on Sales rose 3.0% year-over-year to 0.14%; the TTM figure through Mar 2026 stood at 0.23% (down 13.0% YoY), while the FY2025 annual figure was 0.2%, down 6.0% from the prior year.
  • Return on Sales for Q1 2026 stood at 0.14%, up from 0.17% in the prior quarter.
  • The five-year high for Return on Sales was 0.06% in Q3 2024, with the low at 1.53% in Q1 2023.
  • The 5-year median for Return on Sales is 0.17% (2025), against an average of 0.35%.
  • The sharpest annual moves came in 2022 and 2024: Return on Sales plunged 258 bps in 2022, then surged 145 bps in 2024.
  • Longeveron's Return on Sales stood at 0.43% in 2022, then slumped by 101 bps to 0.87% in 2023, then soared by 90 bps to 0.09% in 2024, then tumbled by 97 bps to 0.17% in 2025, then advanced by 19 bps to 0.14% in 2026.
  • Business Quant data shows LGVN's Return on Sales at 0.14% in Q1 2026, 0.17% in Q4 2025, and 0.64% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.00%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 0.00%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -0.05%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 0.00%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.00%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.00%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.00%
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 -0.22%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.26%
Mar 31, 2026 -0.14%
Dec 31, 2025 -0.17%
Sep 30, 2025 -0.64%
Jun 30, 2025 -0.22%
Mar 31, 2025 -0.17%
Dec 31, 2024 -0.09%
Sep 30, 2024 -0.06%
Jun 30, 2024 -0.08%
Mar 31, 2024 -0.08%
Dec 31, 2023 -0.87%
Sep 30, 2023 -0.36%
Jun 30, 2023 -0.27%
Mar 31, 2023 -1.53%
Dec 31, 2022 -0.43%
Sep 30, 2022 -0.54%
Jun 30, 2022 -0.11%
Mar 31, 2022 -0.13%
Dec 31, 2021 2.15%
Sep 30, 2021 -0.99%